Acral FibroChondroMyxoid tumor: imaging features of a new entity

Skeletal Radiology - Tập 50 - Trang 603-607 - 2020
Thomas Le Corroller1,2, Nicolas Macagno3, Hugo Nihous3, Pierre Champsaur1,2, Corinne Bouvier3
1Radiology Department, APHM, Marseille, France
2CNRS, ISM UMR 7287, Aix Marseille University, Marseille, France
3INSERM, MMG, APHM, CHU Timone, Department of Pathology, Aix Marseille University, Marseille, France

Tóm tắt

“Acral FibroChondroMyxoid tumor” (AFCMT) is a recently described distinctive subtype of acral soft tissue tumor that typically arises on the fingers and toes. We herein present the unreported imaging features of AFCMT in a 44-year-old woman. This otherwise healthy patient was referred for a painful, slow-growing, soft tissue mass in the middle finger of her right hand. Initial radiographs and computed tomography showed a small lesion centered in the soft tissue of the ulnar aspect of the proximal phalanx, associated with scalloping of the underlying bone. Magnetic resonance imaging confirmed the presence of a well-circumscribed soft tissue tumor that exhibited relatively high T2-weighted signal intensity and marked enhancement after contrast administration. Subsequent excisional biopsy was performed. Histologically, the tumor was characterized by an abundant stroma displaying fibrous, chondroid, and myxoid areas. By immunohistochemistry, tumor cells stained for CD34, ERG, and focally S100 protein. RNA-sequencing allowed detection of THBS1-ADGFR5 gene fusion which confirmed the diagnosis of AFCMT. At 2-year follow-up, the patient remains free of recurrence. AFCMT is a previously unrecognized entity that may mimic chondroma and should be considered in the differential diagnosis of soft tissue tumors with cartilaginous or myxoid stroma in the extremities.

Tài liệu tham khảo

Bouvier C, Le Loarer F, Macagno N, et al. Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype “acral FibroChondroMyxoid tumors”. Mod Pathol. 2020;33:1360–8. Shon W, Folpe AL, Fritchie KJ. ERG expression in chondrogenic bone and soft tissue tumours. J Clin Pathol. 2015;68:125–9. Varikatt W, Soper J, Simmons G, Dave C, Munk J, Bonar F. Superficial acral fibromyxoma: a report of two cases with radiological findings. Skelet Radiol. 2008;37:499–503. Douis H, Saifuddin A. The imaging of cartilaginous bone tumours. I. Benign lesions. Skelet Radiol. 2012;41:1195–212. Kwee RM, Kwee TC. Calcified or ossified benign soft tissue lesions that may simulate malignancy. Skelet Radiol. 2019;48:1875–90. Amary MF, Bacsi K, Maggiani F, et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcomas and central and periosteal chondromas but not in other mesenchymal tumors. J Pathol. 2011;224:334–43. Amary F, Perez-Casanova L, Ye H, et al. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement. Mod Pathol. 2019;32:1762–71. Moulonguet I, Goettmann S, Zaraa I. Superficial acral fibromyxoma with cartilaginous metaplasia. Am J Dermatopathol. 2019;41:316–7. Hollmann TJ, Bovée JVMG, Fletcher CDM. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases. Am J Surg Pathol. 2012;36:789–98. Antonescu CR, Zhang L, Chang N-E, et al. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosom Cancer. 2010;49:1114–24.